多西他赛联合奥沙利铂和氟尿嘧啶新辅助化疗治疗Ⅲ、Ⅳ期.docNameofjournal:WorldJournalofGastroenterologyESPSManuscriptNO:10007Columns:-JunYu,Wei-JianSun,Ming・DongLuzFei-HaiWang,Dan-SiQi,YiZhang,Pi-HongLi,HeHuang,TaoYou,Zhi-QiangZhengYao-JunYu,Wei-JianSun,Ming-DongLu,Fei-HaiWang,Dan-SiQi,YiZhang,Pi-HongLi,HeHuang,TaoYou,Zhi-QiangZheng,NOH09DiseaseDist.,DepartmentofGeneralSurgery,theSecondAffiliatedHosp让alofWenzhouMedicalUnivers让y,Wenzhou325003,ZhejiangProvince,ChinaAuthorcontributions:YuYJpreparedtheandleadtheresearch;SunWJcollectedpatients7data;LuMDmadesamplegroupinganddelivery;WangFHperformedpreoperativedataanalysisandoperation;QiDSperformedpathologicalexamination;parisonofinfluencingfactors;LiPHperformediconographicalexamination;HuangHmadestatisticsofpatients'data;YouTperformedoperationandsamplegrouping;:Yao-JunYuzMD,,theSecondAffiliatedHospitalofWenzhouMedicalUniversity,,XueyuanRoad,Wenzhou325003,ZhejiangProvince,China,******@Telephone:+86-577-88002709Fax:+86-577-88002739Received:March8,2014Revised:September15,epted:October21,2014Publishedonline:AbstractAIM:::75mg/m2docetaxeland85mg/m2oxaliplatinonday1and1500mg/:Thetumourchanges,postoperativeremissionrate,+partialremission)%.%ofthepatients,w让haremissionrate(pleteresponse+pathologicalsubtotalresponse+pathologicalpartialresponse)%•,followedbygastrointestinalmucosallesions,nausea,:,thetreatmenthasahighincidenceofbonemarrowsuppression,whichshouldbemanagedclinically.©2014BaishidengPub
多西他赛联合奥沙利铂和氟尿嘧啶新辅助化疗治疗Ⅲ、Ⅳ期 来自淘豆网m.daumloan.com转载请标明出处.
